Activation of the NF-κB system in peripheral blood leukocytes from patients with chronic heart failure

European Journal of Heart Failure

Volumn 7, Issue 6, 2005, Pages 984-990

  Jankowska, Ewa A ^a   Von Haehling, Stephan ^b   Czarny, Anna ^c   Zaczynska, Ewa ^c   Kus, Agnieszka ^a   Anker, Stefan D ^b,d   Banasiak, Waldemar ^a   Ponikowski, Piotr ^a  

^a MILITARY HOSPITAL   (Poland)

^b NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^c INSTITUTE OF IMMUNOLOGY AND EXPERIMENTAL THERAPY   (Poland)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Chronic heart failure; Immune activation; Nuclear factor kappa B

Indexed keywords

C REACTIVE PROTEIN; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; IMMUNOGLOBULIN G ANTIBODY; OXYGEN; POLYCLONAL ANTIBODY; TRANSCRIPTION FACTOR REL; LIPOPOLYSACCHARIDE;

ADULT; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORONARY ARTERY DISEASE; FEMALE; HEART FAILURE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; LEUKOCYTE; MAJOR CLINICAL STUDY; MALE; OXYGEN CONSUMPTION; PERIPHERAL EDEMA; PRIORITY JOURNAL; PROSPECTIVE STUDY; BLOOD; CASE CONTROL STUDY; COMPARATIVE STUDY; CONGESTIVE HEART FAILURE; CORONARY ARTERY ATHEROSCLEROSIS; CYTOLOGY; DISEASE COURSE; DRUG EFFECT; HOSPITALIZATION; IMMUNOHISTOCHEMISTRY; MACROPHAGE; METABOLISM; MIDDLE AGED; PATHOPHYSIOLOGY; PROBABILITY; PROGNOSIS; REFERENCE VALUE; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

CASE-CONTROL STUDIES; CORONARY ARTERIOSCLEROSIS; DISEASE PROGRESSION; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; IMMUNOHISTOCHEMISTRY; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; NF-KAPPA B; PROBABILITY; PROGNOSIS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SEVERITY OF ILLNESS INDEX;

EID: 26644469057     PISSN: 13889842     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejheart.2005.05.013     Document Type: Article

References (41)

1. M. Rauchhaus, W. Doehner, and D.P. Francis Plasma cytokine parameters and mortality in patients with chronic heart failure Circulation 102 2000 3060 3067
2. A. Deswal, N.J. Petersen, A.M. Feldman, J.B. Young, B.G. White, and D.L. Mann Cytokines and cytokine receptors in advanced heart failure. An analysis of the cytokine database from the Vesnarinonre Trial (VEST) Circulation 103 2001 2055 2059
3. D.L. Mann Inflammatory mediators and the failing heart: past, present, and the foreseeable future Circ Res 91 2002 988 998
4. S.D. Anker, P.P. Ponikowski, and A.L. Clark Cytokines and neurohormones relating to body composition alterations in the wasting syndrome of chronic heart failure Eur Heart J 20 1999 683 693
5. K. Shan, K. Kurrelmeyer, and Y. Seta The role of cytokines in disease progression in heart failure Curr Opin Cardiol 12 1997 218 223
6. S. von Haehling, E.A. Jankowska, and S.D. Anker Tumour necrosis factor-alp ha and the failing heart - pathophysiology and therapeutic implications Basic Res Cardiol 99 2004 18 28
7. J. Caamano, and C.A. Hunter NF-κB family of transcription factors: central regulators of innate and adaptive immune functions Clin Microb Rev 15 2002 414 429
8. M. Karin, and A. Lin NF-kappaB at the crossroads of life and death Nat Immunol 3 2002 221 227
9. G. Valen, Z.Q. Yan, and G.K. Hansson Nuclear factor kappa-B and the heart JACC 38 2001 307 314
10. S. Ghosh, and M. Karin Missing pieces in the NF-κB puzzle Cell 109 2002 S81 S96
11. H.L. Pahl Activators and target genes of Rel/NF-kappaB transcription factors Oncogene 18 1999 6853 6866
12. D.L. Maass, D.P. Hybki, J. White, and J.W. Horton The time course of cardiac NF-kappaB activation and TNF-alpha secretion by cardiac myocytes after burn injury: contribution to burn-related cardiac contractile dysfunction Shock 17 2002 293 299
13. G. Wright, I.S. Singh, and J.D. Hasday Endotoxin stress-response in cardiomyocytes: NF-kappaB activation and tumor necrosis factor-alpha expression Am J Physiol Heart Circ Physiol 282 2002 H872 H879
14. V. Adams, B. Nehrhoff, U. Spate, A. Linke, P.C. Schulze, and A. Baur Induction of iNOS expression in skeletal muscle by IL-1beta and NFkappaB activation: an in vitro and in vivo study Cardiovasc Res 54 2002 95 104
15. A. Yndestad, A.M. Holm, F. Muller, S. Simonsen, S.S. Froland, and L. Gullestad Enhanced expression of inflammatory cytokines and activation markers in T-cells from patients with chronic heart failure Cardiovasc Res 60 2003 141 146
16. S. Genth-Zotz, S. von Haehling, A.P. Bolger, P.R. Kalra, R. Wensel, and A.J. Coats Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure Am J Cardiol 90 2002 1226 1230
17. A. Yndestad, J.K. Damas, and H. Geir Eiken Increased gene expression of tumor necrosis factor superfamily ligands in peripheral blood mononuclear cells during chronic heart failure Cardiovasc Res 54 2002 175 182
18. S.P. Zhao, and T.D. Xu Elevated tumor necrosis factor alpha of blood mononuclear cells in patients with congestive heart failure Int J Cardiol 71 1999 257 261
19. J. Niebauer, H.D. Volk, and M. Kemp Endotoxin and immune activation in chronic heart failure: a prospective cohort study Lancet 353 1999 1838 1842
20. S.D. Anker, K.R. Egerer, H.D. Volk, W.J. Kox, P.A. Poole-Wilson, and A.J. Coats Elevated soluble CD14 receptors and altered cytokines in chronic heart failure Am J Cardiol 79 1997 1426 1430
21. S.E. Mcnulty, R. Del Rosario, D. Cen, F.L. Meyskens Jr., and S. Yang Comparative expression of NFκB proteins in melanocytes of normal skin vs. benign intradermal naevus and human metastatic melanoma biopsies Pigment Cell Res 17 2004 173 180
22. T.F. Barth, J.I. Martin-Subero, and S. Joos Gains of 2p involving the REL locuc correlate with nuclear c-Rel protein accumulation in neoplastic cells of classical Hodgkin lymphoma Blood 101 2003 3681 3688
23. L. Hart, V.L. Krishnan, I.M. Adcock, P.J. Barnes, and K.F. Chung Activation and localisaton of transcription factor, nuclear factor-κB, in asthma Am J Respir Crit Care Med 158 1998 1585 1592
24. M. Yokota, J. Kambayashi, T. Tanaka, T. Tsujinaka, M. Sakon, and T. Mori A simple turbidimetric time assay of the endotoxin in plasma J Biochem Biophys Methods 18 1989 97 104
25. S.M. Opal, P.J. Scannon, and J.L. Vincent Relationship between plasma levels of lipopolysaccharide (LPS) and LPS-binding protein in patients with severe sepsis and septic shock J Infect Dis 180 1999 1584 1589
26. T.P. Chua, P. Ponikowski, and D. Harrington Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure J Am Coll Cardiol 29 1997 1585 1590
27. P. Ponikowski, D.P. Francis, and M.F. Piepoli Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance: marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis Circulation 103 2001 67 972
28. P. Libby, and P.M. Ridker Inflammation and atherosclerosis: role of C-reactive protein in risk assessment Am J Med 116 Suppl 6A 2004 9S 16S
29. M. Hoffman, A. Blum, R. Baruch, E. Kaplan, and M. Benjamin Leukocytes and coronary heart disease Atherosclerosis 172 2004 1 6
30. S. Frantz, S. Stoerk, S. Ok, H. Wagner, C.E. Angermann, and G. Ertl Effect of chronic heart failure on nuclear factor kappa B in peripheral leukocytes Am J Cardiol 94 2004 671 673
31. S.D. Anker, and S. von Haehling Inflammatory mediators in chronic heart failure: an overview Heart 90 2004 464 470
32. S. Vonhof, B. Brost, M. Stille-Siegener, I.M. Grumbach, H. Kreuzer, and H.R. Figulla Monocyte activation in congestive heart failure due to coronary artery disease and idiopathic dilated cardiomyopathy Int J Cardiol 63 1998 237 244
33. A.P. Bolger, R. Sharma, and S. von Haehling Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure Am J Cardiol 90 2002 384 389
34. D.L. Mann, J.J. McMurray, M. Packer, K. Swedberg, J.S. Borer, and W.S. Colucci Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL) Circulation 109 2004 1594 1602
35. E.S. Chung, M. Packer, K.H. Lo, A.A. Fasanmade, J.T. Willerson Anti-TNF Therapy Against Congestive Heart Failure Investigators Randomized, double-blind, placebo-controlled, pilot trial of infliximab, a chimeric monoclonal antibody to tumor necrosis factor-alpha, in patients with moderate-to-severe heart failure: results of the anti-TNF Therapy Against Congestive Heart Failure (ATTACH) trial Circulation 107 2003 3133 3140
36. S.D. Anker, and A.J. Coats How to recover from renaissance? The significance of the results of recover, renaissance, renewal and attach Int J Cardiol 86 2002 123 130
37. G. Torre-Amione, F. Sestier, B. Radovancevic, and J. Young Effects of a novel immune modulation therapy in patients with advanced chronic heart failure: results of a randomized, controlled, phase II trial J Am Coll Cardiol 44 2004 1181 1186
38. E. Jimi, K. Aoki, H. Saito, F. D'Acquisto, M.J. May, and I. Nakamura Selective inhibition of NF-kappa B blocks osteoclastogenesis and prevents inflammatory bone destruction in vivo Nat Med 10 2004 617 624
39. A. Aljada, R. Garg, H. Ghanim, P. Mohanty, W. Hamouda, and E. Assian Nuclear factor-kappaB suppressive and inhibitor-kappaB stimulatory effects of troglitazone in obese patients with type 2 diabetes: evidence of an antiinflammatory action? J Clin Endocrinol Metab 86 2001 3250 3256
40. H. Bohrer, F. Qiu, and T. Zimmermann Role of NFκB in the mortality of sepsis J Clin Invest 100 1997 972 985
41. M. Fujihara, M. Muroi, K. Tanamoto, T. Suzuki, H. Azuma, and H. Ikeda Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex Pharmacol Ther 100 2003 171 194